IRLA Stock Valuation & Analysis - InvestViable

Stock Screener

Valuator

Education

Pricing

Community

Eren Tayler

Verified

Pass verification

Sign out

Home

Stock Screener

Valuator

Education

Pricing

Community

Institutional-grade investment tools for everyone. Built in Sweden.

Platform

Stock Screener

Valuator

Investment Score

Community

Education

Company

About

Pricing

Contact

Legal

Terms of Service

Privacy Policy

Cookie Policy

© 2026 INVESTVIABLE. All rights reserved.

IRLA Stock Valuation & Analysis - InvestViable

IRulya Therapeutics Inc.

S

NASDAQ

IRLA

Last Price

US $32.03

KEY FIGURES

MKT CAP

$32.6M

EPS

TTM

$-15.08

EPS Growth (1Y)

28.24%

PEG

TTM

N/M

P/E

TTM

N/M

P/S

TTM

-

YIELD

—

GROWTH (5Y CAGR)

Revenue

-

EBITDA

-

Cash flow

Base valuations

Base Cash Flow Valuation (DCF)

Fair Value

N/A

Market $32.03

—

Default assumptions

Base EBITDA Valuation

Fair Value

N/A

Market $32.03

—

Default assumptions

Base Earnings Fair Value

S

No messages

Performance & Financial Health

Profit margin

Current Ratio

Capital Returns

-413.28%

Return on equity

ROIC: -104.64%

Valuation History

-

Price to Earnings

EV/EBITDA: 1.1X

Cash flow

Profit margin

-

Fair Value

N/A

Market $32.03

—

Default assumptions

Base valuations use default assumptions. Customize in the Valuator.